Skip to content

Close Obstructive Sleep Apnea (OSA) Trial

Patent Foramen Ovale Closure on Newly Diagnosed Patients With Obstructive Sleep Apnea and Refractory Hypoxia: A Pilot Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06113562
Enrollment
0
Registered
2023-11-02
Start date
2025-02-01
Completion date
2025-02-11
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea, Patent Foramen Ovale

Brief summary

The aim of this study is to evaluate the benefits of patent foramen ovale (PFO) closure on patients with obstructive sleep apnea (OSA) and persistent hypoxia despite optimal therapy.

Interventions

PROCEDUREPFO closure

The participants will receive a onetime closure of a small hole in heart. The procedure usually takes up to an hour. The procedure is done with local anesthesia and conscious sedation. A catheter is inserted into a vein in upper thigh and threaded to heart to deploy the closure device. Either Gore septal occluder or Amplatzer PFO occluder

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Individuals diagnosed with severe OSA, defined as an apnea-hypopnea index (AHI) greater than 30, associated with nocturnal saturation below 90%, as determined by a sleep medicine specialist using polysomnography. 2. Individuals need to have a patent foramen ovale documented by echocardiography.

Exclusion criteria

1. Individuals unable to take aspirin, clopidogrel, and/or ticagrelor. 2. Pregnant individuals or those who become pregnant during the course of the study will be automatically withdrawn.

Design outcomes

Primary

MeasureTime frameDescription
changes in the apnea hypoxia indexbaseline and then up to 3 months after the studyThe Apnea hypopnea index that ranges from: 0 to 5 is normal 5 to15 is mild 15 to 30 is moderate greater than 30 is severe.
change in mean nocturnal oxygen saturationbaseline and then up to 3 months after the studyOxygen saturation will be measured in percentage. Ranges from 0 to 100 percent. The higher the percent the higher the oxygen saturation.
change in duration of nocturnal oxygen desaturation duration.baseline and then up to 3 months after the studyWill be measured in seconds.

Secondary

MeasureTime frameDescription
change in fatigue as measured by the Fatigue Severity Scale.baseline and then up to 3 months after the studyEach item is scored between 1 and 7 (1 = strongly disagree, 7 = totally agree) in the scale consisting of 9 items that can be applied by individuals in a simple way. The total score range of the scale is 9-63. The total score is calculated by taking the average of 9 items. Accordingly, the lowest average score to be obtained is 1, and the highest average score is 7. The cut-off value was set at 4 and above to diagnose pathological fatigue. The lower the total score, the less fatigue.
change in quality of life as measured by the patient global impression of change scale.baseline and then up to 3 months after the studyChange Scale: Adapted Patient Clinical Global Impression of Improvement (CGI-I) scale rated by the patient is a 7-point scale of improvement from 'very much improved' to 'very much worse'. 'Very much improved' means a better outcome.
changes in functional independence measurebaseline and then up to 3 months after the studyThe Functional independence measure (FIM) is an 18-item instrument comprising 13 motor items and 5 cognitive items, with each item graded on a 7-point ordinal scale (1 denotes complete dependence and 7 denotes complete independence), including the ability to perform activities of daily living (ADLs) across 6 areas (self-care, sphincter control, transfers, locomotion, communication, and social cognition). Total admission FIM (Ta-FIM) scores, total discharge FIM (Td-FIM) scores (18 - 126), motor FIM (m-FIM) sub-scores (13 - 91) and cognitive FIM (c-FIM) sub-scores (5 - 35), were tabulated.
change in quality of sleep as measured by the Epworth Sleepiness Scalebaseline and then up to 3 months after the studyEpworth Sleepiness Scale: The Epworth Sleepiness Scale is widely used in the field of sleep medicine as a subjective measure of a patient's sleepiness. The test is a list of eight situations in which you rate your tendency to become sleepy on a scale of 0, no chance of dozing, to 3, high chance of dozing.
Change in physical activity as measured by Godin Leisure time physical activity questionnaire.baseline and then up to 3 months after the studySelf-reported leisure time physical activity as assessed by the Godin Leisure time physical activity questionnaire in all participants. Score range from 0 upwards, with higher scores indicating more leisure time physical activity.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026